Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ocuvite Duo
- Development stage
- Unknown
- Lead developer
- Bausch + Lomb
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Ocuvite Duo is a multi-ingredient nutritional supplement developed by Bausch + Lomb specifically designed to support eye health and mitigate the progression of age-related macular degeneration (AMD). The formulation typically includes a combination of the carotenoids lutein and zeaxanthin, omega-3 fatty acids (DHA and EPA), antioxidant vitamins (C and E), and essential minerals (Zinc and Copper). These components work synergistically to increase macular pigment optical density (MPOD), filter high-energy blue light, and neutralize reactive oxygen species within the retina. Clinical studies, such as the LUTEGA trial, have investigated its effects on retinal function using multifocal electroretinography (mfERG) and its ability to replenish essential nutrients that naturally deplete with age.
- Brand names
- Ocuvite DuoOcuvite
- Other names
- Ocuvite Lutein & Omega-3
02
Targets
STARD3 (StAR-related lipid transfer domain protein 3)Misfolded SOD1GSTP1 (Glutathione S-transferase P)
Beyond the preview
Go deeper on Ocuvite Duo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ocuvite Duo.